VARIATION IN INTERLEUKIN 28B GEN PREDICTS RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HEPATITIS C VIRUS-COINFECTED PATIENTS

被引：0
|
作者：
Neukam, K. [1 ]
Caruz, A. [2 ]
Rivero, A.
Roldan, C. [1 ]
Salas, I. [2 ]
Camacho, A.
Macias, J. [1 ]
Martinez, A. [3 ]
Palomares, J. C. [4 ]
Pineda, J. A. [1 ]
机构：
[1] Hosp Univ Valme, Infect Dis Unit, Seville, Spain
[2] Univ Jaen, Fac Sci, Immunogenet Unit, Jaen, Spain
[3] Hosp Univ Reina Sofia, Mol Genet Lab, Unit Clin Anal, Cordoba, Spain
[4] Hosp Univ Valme, Microbiol Unit, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)61174-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S453 / S453
页数：1
相关论文
共 50 条
  • [1] Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
    Mira, Jose A.
    Garcia-Rey, Silvia
    Rivero, Antonio
    de los Santos-Gil, Ignacio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    Marquez, Manuel
    Merino, Dolores
    Rios-Villegas, Maria J.
    Macias, Juan
    Rivero-Juarez, Antonio
    Pineda, Juan A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1719 - 1726
  • [2] Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
    Pineda, Juan A.
    Caruz, Antonio
    Rivero, Antonio
    Neukam, Karin
    Salas, Irene
    Camacho, Angela
    Palomares, Jose C.
    Mira, Jose A.
    Martinez, Antonio
    Roldan, Carmen
    de la Torre, Julian
    Macias, Juan
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (07) : 788 - 795
  • [3] Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
    Mira, Jose A.
    Gutierrez-Valencia, Alicia
    Gil, Ignacio De los Santos
    Merino, Dolores
    Rivero, Antonio
    Rios-Villegas, Maria J.
    Delgado, Marcial
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Torres-Tortosa, Manuel
    Omar, Mohamed
    Angel Lopez-Ruz, Miguel
    Macias, Juan
    Arponen, Sari
    Pineda, Juan A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : E84 - E91
  • [4] Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis
    Mira, Jose A.
    Rivero-Juarez, Antonio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    de los Santos-Gil, Ignacio
    Macias, Juan
    Merino, Dolores
    Marquez, Manuel
    Rios-Villegas, Maria J.
    Gea, Isabel
    Merchante, Nicolas
    Rivero, Antonio
    Torres-Cornejo, Almudena
    Pineda, Juan A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1646 - 1653
  • [5] IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
    Rallon, Norma I.
    Soriano, Vincent
    Naggie, Susanna
    Restrepo, Clara
    Goldstein, David
    Vispo, Eugenia
    McHutchison, John
    Benito, Jose M.
    [J]. AIDS, 2011, 25 (08) : 1025 - 1033
  • [6] Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients
    Bedimo, Roger
    Kang, Minhee
    Tebas, Pablo
    Overton, Edgar T.
    Hollabaugh, Kimberly
    McComsey, Grace
    Bhattacharya, Debika
    Evans, Christopher
    Brown, Todd T.
    Taiwo, Babafemi
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (04) : 325 - 328
  • [7] Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
    De Nicola, Stella
    Aghemo, Alessio
    Rumi, Maria Grazia
    Galmozzi, Enrico
    Valenti, Luca
    Soffredini, Roberta
    De Francesco, Raffaele
    Prati, Gian Maria
    D'Ambrosio, Roberta
    Cheroni, Cristina
    Donato, Maria Francesca
    Colombo, Massimo
    [J]. HEPATOLOGY, 2012, 55 (02) : 336 - 342
  • [8] PREDICTION OF RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN BY INTERLEUKIN 28B GENOTYPE IS MODIFIED BY SNPS AT MULTIPLE GENES IN HIV/HEPATITIS C VIRUS GENOTYPE 1/4-COINFECTED PATIENTS
    Neukam, K.
    Caruz, A.
    Barreiro, P.
    Rivero-Juarez, A.
    Merino, D.
    Marquez, M.
    Perez-Navarro, E.
    Soriano, V.
    Rivero, A.
    Pineda, J. A.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S363 - S363
  • [9] The comparison of early virologic response to pegylated interferon plus ribavirin combination therapy in hepatitis B virus/hepatitis C virus-coinfected and hepatitis C virus infected patient groups
    Ceylan, Bahadir
    Fincanci, Muzaffer
    Muderrisoglu, Cuneyt
    Eren, Gulhan
    Soysal, Ferda
    [J]. KLIMIK JOURNAL, 2008, 21 (03) : 97 - 100
  • [10] Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, Firouze
    Goderel, Isabelle
    Lapidus, Nathanael
    Driss, Henda
    Simon, Anne
    Rosenthal, Eric
    Morand, Patrice
    Lunel-Fabiani, Francoise
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Carrat, Fabrice
    [J]. AIDS, 2008, 22 (11) : 1385 - 1387
12345